Nicole Forster - Ryman Healthcare Group Shared Services Manager
| RYHTY Stock | USD 12.86 0.19 1.46% |
Executive
Ms. Nicole Forster is an Chief People and Technology Officer of the company. Nicole joined Ryman in 2011 as a senior human resources advisor. Before joining Ryman, Nicole worked in a variety of human resource and healthcarerelated roles. since 2018.
| Tenure | 6 years |
| Phone | 64 3 366 4069 |
| Web | https://www.rymanhealthcare.co.nz |
Ryman Healthcare Management Efficiency
Ryman Healthcare's management efficiency ratios could be used to measure how well Ryman Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Bridget Sherick | Select Medical Holdings | N/A | |
| William Zima | Concord Medical Services | N/A | |
| Jing Zhang | Concord Medical Services | 49 | |
| Bill Priest | Acadia Healthcare | N/A | |
| Benjamin Adams | InnovAge Holding Corp | 60 | |
| Matt Huray | InnovAge Holding Corp | N/A | |
| Andrew Price | Encompass Health Corp | 57 | |
| Cheryl Levy | Encompass Health Corp | 58 | |
| John Duggan | Select Medical Holdings | N/A | |
| Langham MBA | Enhabit | 47 | |
| MS DO | Encompass Health Corp | 64 | |
| Kenneth Shepard | ModivCare | 43 | |
| Cara Babachicos | InnovAge Holding Corp | N/A | |
| Barbara CPA | ModivCare | 60 | |
| Nathan Vaughn | ModivCare | N/A | |
| Brian Rusignuolo | Select Medical Holdings | 48 | |
| Rauly Gutierrez | InnovAge Holding Corp | N/A | |
| RN BSN | Enhabit | 66 | |
| Matthew Callister | Concord Medical Services | 50 | |
| Mark Palmenter | Acadia Healthcare | N/A | |
| Gretchen Hommrich | Acadia Healthcare | N/A | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 |
Ryman Healthcare Leadership Team
Elected by the shareholders, the Ryman Healthcare's board of directors comprises two types of representatives: Ryman Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ryman. The board's role is to monitor Ryman Healthcare's management team and ensure that shareholders' interests are well served. Ryman Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ryman Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Claire Higgins, Non-Executive Independent Director | ||
| Anthony Leighs, Independent Director | ||
| Cameron Holland, Chief Australia | ||
| Richard Umbers, Group Exec | ||
| Gordon MacLeod, CFO, Deputy Chief Executive and Company Secretary | ||
| Kevin Hickman, Co-Founder, Director and Member of Remuneration and Nominations Committee | ||
| Taylor Allison, Design Manager | ||
| Michelle Perkins, IR Contact Officer | ||
| Simon Challies, CEO, Managing Director, Executive Director | ||
| Tom Brownrigg, Construction Manager | ||
| Jo Appleyard, Independent Non-Executive Director | ||
| Jenn Poskitt, Marketing Manager | ||
| Philip Mealings, Property and Purchasing Manager | ||
| George Savvides, Independent Director | ||
| Douglas McKay, Independent Director | ||
| Cheyne Chalmers, Chief Zealand | ||
| Debbie McClure, Group Sales Manager | ||
| Warren Bell, Independent Non-Executive Director | ||
| David Bennett, Group Officer | ||
| Deborah Marris, G Sec | ||
| Marsha Cadman, Chief Officer | ||
| Rick Davies, Chief Officer | ||
| Andrew Mitchell, Development Manager | ||
| David Kerr, Independent Non-Executive Chairman of the Board | ||
| Geoffrey Cumming, Director | ||
| MaryAnne Stone, Chief Officer | ||
| David King, Corporate Affairs Manager | ||
| Chris BE, Chief Officer | ||
| Barbara ReynenRose, Operations & Clinical Services Manager | ||
| Nicole Forster, Group Shared Services Manager |
Ryman Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ryman Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 | |||
| Profit Margin | 1.13 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.91 B | |||
| Shares Outstanding | 100 M | |||
| Price To Earning | 10.13 X | |||
| Price To Book | 0.85 X | |||
| Price To Sales | 3.74 X | |||
| Revenue | 503.76 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ryman Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ryman Healthcare's short interest history, or implied volatility extrapolated from Ryman Healthcare options trading.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryman Healthcare Ltd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Ryman Pink Sheet analysis
When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |